Targeting IL-17A in Multiple Myeloma: A Potential Novel Therapeutic Approach in Myeloma

We have previously demonstrated that interleukin-17A (IL-17) producing Th17 cells are significantly elevated in blood and bone marrow (BM) in multiple myeloma (MM) and IL-17A promotes MM cell growth via the expression of IL-17 receptor. In this study, we evaluated anti-human IL-17A human monoclonal...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Leukemia
Main Authors: Prabhala, Rao H., Fulciniti, Mariateresa, Pelluru, Dheeraj, Rashid, Naim, Nigroiu, Andreea, Nanjappa, Puru, Pai, Christine, Lee, Saem, Prabhala, Nithya S., Bandi, Rajya Lakshmi, Smith, Robert, Lazo-Kallanian, Suzan B., Valet, Sonia, Raje, Noopur, Gold, Jason S., Richardson, Paul G., Daley, John F., Anderson, Kenneth C., Ettenberg, Seth A., Di Padova, Franco, Munshi, Nikhil C.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2015
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4740263/
https://ncbi.nlm.nih.gov/pubmed/26293646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2015.228
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים